ARCHIVES

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program

February 5, 1999

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Funding Opportunities

April 26, 2002

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

May 15, 1981